BlackRock Advisors’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q2 | – | Sell |
-187,036
| Closed | -$18.2M | – | 3760 |
|
|
2015
Q1 | $18.2M | Buy |
187,036
+167,659
| +865% | +$16.4M | 0.02% | 578 |
|
|
2014
Q4 | $1.8M | Buy |
19,377
+3,123
| +19% | +$290K | ﹤0.01% | 1210 |
|
|
2014
Q3 | $1.12M | Sell |
16,254
-6,338
| -28% | -$436K | ﹤0.01% | 1346 |
|
|
2014
Q2 | $2.37M | Sell |
22,592
-2,336
| -9% | -$245K | ﹤0.01% | 1106 |
|
|
2014
Q1 | $2.07M | Sell |
24,928
-97,979
| -80% | -$8.13M | ﹤0.01% | 1150 |
|
|
2013
Q4 | $7.96M | Sell |
122,907
-26,859
| -18% | -$1.74M | 0.01% | 852 |
|
|
2013
Q3 | $9.49M | Sell |
149,766
-167,597
| -53% | -$10.6M | 0.01% | 793 |
|
|
2013
Q2 | $13.3M | Buy |
+317,363
| New | +$13.3M | 0.01% | 679 |
|